The gene implicated in epilepsy, progressive myoclonic 1B (EPM1B) is PRICKLE1, one of a group of related genes in human, PRICKLE1-4. OMIM includes EPM1B in the phenotypic series epilepsy, progressive myoclonic (FBhh0000319). A model of epilepsy using the orthologous fly gene prickle (Dmel\pk), is described in the human disease model report epilepsy, PRICKLE-related (FBhh0000321).
[updated June 2016 by FlyBase; FBrf0222196]
Progressive myoclonic epilepsy (PME) is characterized by the presence of both muscle contractions (myoclonus) and seizures (epilepsy). Myoclonus occurs separately from seizures; the two types of symptoms respond differently to the same drugs and may evolve differently during the course of the disease. Myoclonus is frequently a greater problem than seizures, because it less amenable to control by available drugs. [from NORD, Progressive Myoclonus Epilepsy; 2016.06.13]
Progressive myoclonic epilepsy refers to a clinically and genetically heterogeneous group of neurodegenerative disorders, usually with debilitating symptoms, although severity varies. [from MIM:254800; 2016.06.13]
[EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B](https://omim.org/entry/612437)
[PRICKLE PLANAR CELL POLARITY PROTEIN 1; PRICKLE1](https://omim.org/entry/608500)
Progressive myoclonic epilepsy-1B (EPM1B) is characterized by early onset (during childhood), with onset of gait ataxia before the onset of seizures; cognitive function is not typically affected. [from MIM:612437; 2016.06.13]
Progressive myoclonic epilepsy-1B (EPM1B) is caused by homozygous mutation in the PRICKLE1 gene.